Nioxin Scalp Recovery
NDC Package 69282-005-50

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Nioxin Scalp Recovery is a . Marketed by The Wella Corporation, this product is identified by NDC 69282-005 and is authorized under FDA application M032.

Identification & Billing

NDC Package Code
69282-005-50
Package Description
1 BOTTLE, PLASTIC in 1 CARTON / 50 mL in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
69282000550

Clinical Specifications

Proprietary Name
Nioxin Scalp Recovery Medicating Cleanser
Dosage Form
-

Regulatory & Marketing

Labeler Name
The Wella Corporation
FDA Application #
M032
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
07-01-2016
End Marketing Date
12-31-2024
Listing Expiration
12-31-2024
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (69282-005). Click a package code to view its specific billing and regulatory data.

1000 mL in 1 BOTTLE, PLASTIC
200 mL in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69282-005-50 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 50 ml in 1 bottle, plastic of Nioxin Scalp Recovery Medicating Cleanser, labeled by The Wella Corporation. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by The Wella Corporation on July 01, 2016. The current certification is valid through December 31, 2024.

How is this The Wella Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69282000550. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69282-005-50
11-Digit CMS (5-4-2)
69282-0005-50

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.